Data availability
The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request.
References
Zhang D, Wu H, Kong Q (2021) Letter to the editor on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.” Int Orthop 45(5):1365–1366
Dong H, Lu Y, Luo Y (2021) Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial". Int Orthop. https://doi.org/10.1007/s00264-021-05036-y
Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087
Kvederas G, Porvaneckas N, Andrijauskas A et al (2013) A randomized double-blind clinical trial of tourniquet application strategies for total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(12):2790–2799
Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 86(4):561–5
Author information
Authors and Affiliations
Contributions
All authors have approved the manuscript and agree with submission.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
No consent for participation is required due to no personal data included.
Consent for publication
All authors have approved the manuscript and agree with submission to International Orthopaedics.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, L., Li, Y., Liu, D. et al. Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”. International Orthopaedics (SICOT) 45, 2167–2168 (2021). https://doi.org/10.1007/s00264-021-05098-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-021-05098-y